Back

Challenges in targeting residual risk in diabetic patients, post ACS

31 August 2019 (15:35 - 15:50)
Organised by:
Congress Presentation Part of: Epigenetics: a new pathway to tackle residual risk? Clinical ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Peter Libby

Mass General Brigham, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor U. Landmesser (Berlin, DE)
Slides Video
Presentation thumbnail
BET inhibition, an epigenetic pathway: how could BET inhibition modulate atherothrombotic risk
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Clinical update on BET inhibition: the patient profile that may benefit from BET inhibition?
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Discussion
Professor U. Landmesser (Berlin, DE) Professor K. Ray (London, GB)
Slides Video

Access the full session

Session thumbnail
Epigenetics: a new pathway to tackle residual risk?

The Event

Event poster

ESC Congress 2019

31 August 2019 15:35 CET